• Greg Fenves Officially Named UT Austin President

    Greg Fenves Officially Named UT Austin President

    Gregory L. Fenves, Cockrell School Dean for 5 Years, will assume the role of President in June.
    » Read more

  • Why UT Is The Energy University

    Why UT Is The Energy University

    ChE professors Tom Edgar and Brian Korgel are included in the first article of a series of stories examining UT’s strengths as the energy university.
    » Read more

  • Five Named NSF Graduate Research Fellows

    Five Named NSF Graduate Research Fellows

    Department students have earned more NSF Fellowships than any other chemical engineering program nationwide over the past three years, see our 2015 recipients.
    » Read more

  • Researchers Selected for Startup Business Plan Competition

    Researchers Selected for Startup Business Plan Competition

    Taylor Harvey and Aaron Chockla will participate in the world's largest student startup competition soon and they need your vote!
    » Read more

Did you know?

  • The department has a network of more than 6,500 alumni world-wide
  • In the past 5 years, faculty have been issued 84 patents across 35 unique technologies
  • The department has more than 700 undergraduate students
  • The department has two Institute of Medicine members
  • U.S. News & World Report ranks the McKetta graduate program No.6
  • Our faculty publish an average of 250 papers per year
  • The department hosts nine National Academy of Engineering members
  • Average starting salary for B.S. graduates is $73,938
  • U.S. News & World Report ranks the undergraduate program No. 6
  • The average starting salary for Ph.D. graduates is $95,423

    Meet our Faculty

    5375691237_49c85d372a_m
    Lydia Contreras

    Assistant Professor Contreras works in Bioengineering with specific interests in RNA-protein interactions, RNA-protein folding; Novel molecular tools for intracellular studies of RNA-metabolism; Protein engineering for novel mechanisms of molecular recognition; Diagnostics for RNA-related diseases; Discovery of drugs targeting RNAs; Optimization strategies for therapeutic RNA/protein expression.

Visit our faculty directory